ONCOLOGY
Clinical and Translational User Group Meetings +
Clinical Oncology Summit: Part 1 (North & South America)
A two-part event, the Break the Data Bottleneck Summit will explore how small to...
Clinical and Translational User Group Meetings +
Clinical Oncology Summit: Part 1 (Europe, Asia, Africa, Australia)
A two-part event, the Break the Data Bottleneck Summit will explore how small to...
QIAGEN IPA
Systems analysis of cancer cell lines for drug target discovery
Cancer cell line models have been a cornerstone of cancer research for decades. Cancer...
Gene Variant Databases
Access to real-world data and 2 decades of expert curation
Across oncology applications, from research to molecular testing and pharmaceutical...
QCI Interpret for Oncology
Comparison of methods in routine somatic diagnostics
Dr. Mattia Schmid from UniLabs, Switzerland compares the methods of molecular oncology...
Gene Variant Databases
Identify meaningful mutations in somatic tumor testing
From Information Overload to Actionable Insights Precision medicine is transforming...
QIAGEN OmicSoft
Drug Target and Biomarker Investigation using OmicSoft OncoLand
In this 90-minute training, attendees will learn how to use basic expression analysis...
COSMIC
Identify actionable mutations in East Asian cancer patients with COSMIC
COSMIC, the Catalogue Of Somatic Mutations In Cancer...
QCI Interpret for Oncology
Gaining insights with transcriptomic profiling and mechanistic modeling
In this webinar, Moritz Schütte, head of next-generation sequencing data analysis at...
Clinical and Translational User Group Meetings +
Generate oncologist-ready clinical reports from comprehensive panels
Ruth Burton, Ph.D., Clinical Application Specialist, QIAGEN Digital Insights explains...
Clinical and Translational User Group Meetings +
Confidence and trust: Deliver valuable clinical insights with high-quality...
Ben Turner, Director of Bioinformatics Enterprise Solutions, QIAGEN Digital Insights...
Clinical and Translational User Group Meetings +
Going beyond: Molecular evidence for off-label therapy use
Kathryn Bungartz, Ph.D., Associate StaffField Application Scientist, QIAGEN Digital...